Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Kidney disease probably caused by obesity, find scientists
A study led by Manchester University NHS Foundation Trust (MFT) and The University of Manchester researchers has revealed that obesity is likely to cause an increased risk of kidney disease.
“We wanted to help others in future” – mum of baby who took part in pioneering CBD research in Manchester shares her experience
Pioneering research at Saint Mary’s Hospital is trialling cannabidiol (CBD) – in conjunction with the NHS standard of care – as a potential treatment for newborns with moderate or severe brain injury.
Hearts, data and technology
Advances in technology and data from pacemakers are alerting Manchester doctors of heart failure patients who may benefit from medical attention.
Trial of wearable health technology for cancer patients opens
A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.
MFT joins UK partners to maximise the benefits of health data
MFT joins a growing group of like-minded organisations working together to realise the benefits of using health data for research and innovation for public benefit.
Participants in pioneering COVID-19 treatment trial encourage others to follow their example
Ground-breaking research taking place at Manchester University NHS Foundation Trust is investigating a pioneering new treatment for COVID-19.
MFT joins international hospital alliance to improve patient care
MFT has joined global partners as part of the Smart Hospital Alliance (SHA) to drive the expansion of cutting-edge digital health technologies for the benefit of our patients and communities.
Early data for multivariant COVID-19 vaccine booster shows promise
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.